Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples